Schizophrenia Clinical Trials

Find Schizophrenia Clinical Trials Near You

Cognitive and Neural Mechanisms of Multidimensional Apathy in Psychiatric Pathologies

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Apathy is defined by quantitative decrease in goal-directed activity in comparison to the person's previous level of functioning. Apathy is a transnosographic symptom, prevalent in many neurological and psychiatric pathologies (specifically in schizophrenia and depression), and almost half of patients suffer from it. It is an important source of burden, affecting both personal and occupational life. Despite its high prevalence and negative consequences, no pharmacological or non-pharmacological treatments exist, the underlying mechanisms of apathy being poorly understood. The main aim of the present study is to advance in our knowledge of cognitive and neural mechanisms of apathy by using a multidimensional model of apathy, distinguishing three forms: executive, emotional and auto-activation/initiative. the investigators hypothesize, independently of the pathology (schizophrenia and depression), the existence of different cognitive deficits underlying each of the 3 subforms of apathy. Indeed, according to the predictions of Levy and Dubois' model (2006), executive disorders underlie the cognitive form of apathy. It may be related to lesions of the dorsolateral prefrontal cortex and the cognitive territory of the basal ganglia. Emotional apathy could be due to motivational disorder. Dysfunctions or lesions in the orbital and medial prefrontal cortex and limbic territories of the basal ganglia may underlie this. Finally, the initiative form, may be a mixed form, with both motivational and executive difficulties. Lesions or dysfunctions may affect both the cognitive and limbic territories of the basal ganglia or the anterior cingulate cortex.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: t
View:

• Inclusion criteria (all subjects):

• age between 18 and 60 years

• men or women volunteers, hospitalized or not

• subject affiliated to an health insurance

• subject having signed an informed consent

⁃ \- presence of DSM-V TR criteria for schizophrenia (American Psychiatric Association, 1994)

⁃ \- presence of DSM-V TR criteria for depression (American Psychiatric Association, 1994)

Locations
Other Locations
France
Service de Psychiatrie, Hôpital Civil, Hôpitaux Universitaires de Strasbourg
RECRUITING
Strasbourg
Contact Information
Primary
Fabrice Berna, MD
fabrice.berna@chru-strasbourg.fr
00333
Backup
Anne Bonnefond, PHD
anne.bonnefond@unistra.fr
00333
Time Frame
Start Date: 2022-01-05
Estimated Completion Date: 2027-03-01
Participants
Target number of participants: 144
Treatments
Experimental: Patients with schizophrenia
* 5 subjective questionnaires~* 4 cognitive tasks with EEG recordings
Experimental: Patients with depression
* 5 subjective questionnaires~* 4 cognitive tasks with EEG recordings
Active_comparator: Healthy controls
* 5 subjective questionnaires~* 4 cognitive tasks with EEG recordings
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Strasbourg, France

This content was sourced from clinicaltrials.gov